The Implementation of a Quality Management System (QMS) According to FACT-Jacie Standards Improves the Safety Level in the Collection, Processing and Clinical Departments of the Bone Marrow Transplantation Program

Abstract

s / Biol Blood Marrow Transplant 21 (2015) S355eS373 S363 perception of issues from transplant centers since the full implementation of the ACA in early 2014. In terms of Medicaid problems, the survey found that transplant centers have considerable issues with Medicaid reimbursement rates (45%), prior authorization issues (46%), benefit restrictions (38%) and coverage for specific clinical indications (32%). Transplant centers issues with Medicare centered on coverage for certain indications (71%) with some concern for the current Medicare reimbursement rate (30%). Commercial payers were rated by transplant centers to have minor (32%) or some issues (43%) when it comes to the scope of overall issues transplant centers face. Respondents gave qualitative responses about how the ACA is impacting their transplant center and patient populations. While a few respondents provided positive anecdotes about expanded patient access to care through the ACA, many respondents discussed network inclusion issues, problems with home health care, benefit confusion and sincere concerns with pharmaceutical benefit restrictions. The survey results will direct the efforts of the NMDP’s Payer Policy team and help to inform the transplant community about common payer challenges.